Blockchain Registration Transaction Record
Nutriband CEO to Showcase Innovation at Emerging Growth Conference
Nutriband Inc. CEO to present at Noble Capital Markets' conference, showcasing AVERSA technology for abuse-deterrent transdermal patches. Learn more about this innovation.

This news is crucial for investors and stakeholders in the pharmaceutical and biotech sectors, as it highlights Nutriband's efforts to combat drug abuse through innovative technology. The presentation offers a unique opportunity to understand the company's strategic direction and the potential impact of its AVERSA technology on the market. For those concerned with pharmaceutical safety and innovation, Nutriband's developments represent a significant step forward in preventing drug misuse and abuse.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xb642e813509eb9408793c4d5a398a49c045ad83ad57ed021dab6cbcf8dfd820e |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | fernZ6Nk-42389f07a5fcfb8792450afe0b6f8814 |